HNI (NYSE:HNI – Get Free Report) is expected to post its Q3 2026 results before the market opens on Tuesday, November 3rd. Analysts expect the company to announce earnings of $1.40 per share and revenue of $1.60 billion for the quarter. HNI has set its FY 2026 guidance at 4.150-4.330 EPS and its Q3 2026 guidance at 1.160-1.190 EPS. Interested persons can check the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 11:00 AM ET.
HNI (NYSE:HNI – Get Free Report) last issued its earnings results on Thursday, July 30th. The business services provider reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.23. HNI had a net margin of 0.10% and a return on equity of 13.66%. The firm had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.48 billion. During the same quarter last year, the business posted $1.11 earnings per share. The company’s quarterly revenue was up 120.7% on a year-over-year basis. On average, analysts expect HNI to post $4.19 EPS for the current fiscal year and $4.74 EPS for the next fiscal year.
HNI Trading Up 0.3%
NYSE HNI opened at $47.70 on Tuesday. The company has a market cap of $3.44 billion, a price-to-earnings ratio of 530.07, a price-to-earnings-growth ratio of 0.76 and a beta of 0.93. HNI has a twelve month low of $28.93 and a twelve month high of $52.79. The company has a quick ratio of 0.88, a current ratio of 1.36 and a debt-to-equity ratio of 0.76. The business’s fifty day moving average is $47.37 and its 200 day moving average is $41.89.
HNI Dividend Announcement
Insider Buying and Selling
In other HNI news, CEO Jeffrey Lorenger sold 1,504 shares of the company’s stock in a transaction on Friday, August 28th. The shares were sold at an average price of $50.00, for a total transaction of $75,200.00. Following the sale, the chief executive officer owned 148,490 shares of the company’s stock, valued at approximately $7,424,500. This represents a 1.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 95,138 shares of company stock worth $4,648,587 over the last quarter. Corporate insiders own 2.15% of the company’s stock.
Wall Street Analysts Forecast Growth
HNI has been the subject of several recent research reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of HNI in a research note on Thursday. Wells Fargo & Company set a $65.00 target price on shares of HNI in a research report on Wednesday, July 15th. Benchmark reiterated a “buy” rating on shares of HNI in a research report on Wednesday, July 15th. Finally, Wall Street Zen raised shares of HNI from a “hold” rating to a “buy” rating in a report on Saturday, September 12th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $65.00.
Check Out Our Latest Research Report on HNI
About HNI
HNI Corporation (NYSE:HNI), headquartered in Muscatine, Iowa, is a workplace and residential building products company. Its businesses serve organizations, businesses, education and government customers, as well as residential consumers through office furnishings and hearth products.
HNI’s workplace furnishings portfolio includes desks, tables, seating, storage, collaborative products and related workplace solutions. Its brands include HON, Allsteel, HBF and Gunlocke, among others. The company sells products through dealers, retailers, e-commerce channels and other distribution partners, primarily serving customers in North America.
Through its hearth products business, HNI manufactures fireplaces, inserts, stoves and related products fueled by gas, wood and pellets.
See Also
- Five stocks we like better than HNI
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for HNI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HNI and related companies with MarketBeat.com's FREE daily email newsletter.
